(Press-News.org) While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to discontinue their treatment. A study involving researchers at Karolinska Institutet in Stockholm has now found that a much lower dose than the standard produces a good effect with fewer adverse reactions in women who have yet to enter the menopause. The study, which has been published in the Journal of Clinical Oncology, can play a significant role in the treatment of cancer.
The anti-hormone drug tamoxifen has been used for over 40 years to reduce the risk of relapse in women who have been treated for hormone-related breast cancer. It is also approved as a prophylactic for women with an inherited higher risk of breast cancer.
Women with dense breasts, which is to say breasts with relatively high amounts of firbroglandular tissue to fat tissue, run a four to six-times higher risk of developing breast cancer.
Both dense breast tissue and tumours appear white in mammograms, which makes cancer difficult to detect. Tamoxifen reduces the mammographic density of the breast.
Despite the fact that tamoxifen reduces the risk of breast cancer by up to 40 per cent, it is used relatively infrequently as a prophylactic for healthy women with an increased risk of the disease.
Almost half of the women who take tamoxifen to prevent recurrence after a lumpectomy discontinue treatment prematurely due to a number of known adverse reactions, including menopausal like symptoms such as flushes, sweats, insomnia and various gynaecological problems.
Radiologists, oncologists and researchers at Stockholm Sodersjukhuset Breast Centre, Lund University and Karolinska Institutet have examined the effect of tamoxifen on breast density at a lower dose than the standard 20 mg.
The Karisma study started in 2016 and monitored 1,440 women between the ages of 40 and 74 for just under three years. The women were randomly assigned to six groups of 240, five experimental groups that received a particular dose of tamoxifen (1 2.5, 5, 10 or 20 mg) plus a placebo group.
Before and after the six-month treatment, their mammographic breast density was compared. The women were also asked to report any side effects on a specially designed app.
"Tamoxifen has been shown to reduce mammographic density in women and could be viewed as a proxy for therapy reponse," says principal investigator Professor Per Hall at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet. "The established tamoxifen dose is 20 mg, but it turned out that 2.5, 5 and 10 mg reduced the density just as much as 20 mg. At the same time, the adverse reactions reported by the 2.5 mg group were reduced by 50 per cent compared to women who received the 20 mg dose."
The next step for the researchers is to interrogate whether 2.5 mg tamoxifen also reduces the risk of developing breast cancer and can therefore be used to prevent both a first occurrence and recurrence.
"Such a dose-reduction could potentially increase the number of patients who complete their treatment," he says.
There are currently hardly any preventative strategies for reducing breast cancer with the exception for a small group of women with an inherited increased risk. Per Hall welcomes more work on prophylactic treatments:
"One of the problems is that there is no acceptable medication. Another is that there is no effective method of identifying women at a high risk of breast cancer. At present, we're engaged in a project in which we use AI, Artificial Intelligence, to examine mammographic images to find changes that identify women who will develop breast cancer."
INFORMATION:
The study was supported by grants from the Marit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Kamprad Foundation, the Swedish Cancer Society and the Stockholm-Gotland Regional Cancer Centre. There are no reported conflicts of interest.
Publication: "Low dose tamoxifen for mammographic density reduction - a randomized controlled trial", Mikael Eriksson, Martin Eklund, Signe Borgquist, Roxanna Hellgren, Sara Margolin, Linda Thoren, Ann Rosendahl, Kristina Lang, Jose Tapia, Magnus Backlund, Andrea Discacciati, Alessio Crippa, Marike Gabrielson, Mattias Hammarstrom, Yvonne Wengstrom, Kamila Czene, Per Hall. Journal of Clinical Oncology, online 18 March 2021, doi:10.1200/JCO.20.02598.
Oncotarget published "Quantitative proteome profiling stratifies fibroepithelial lesions of the breast" which reported that the current grading system remains unreliable in differentiating these tumors due to histological heterogeneity and lack of appropriate markers to monitor the sudden and unpredictable malignant transformation of PTs.
The high- throughput quantitative proteomic analysis suggested that FAD and PTs form distinct clusters away from borderline and malignant though there exist marked differences between them.
Interestingly, over-expression of extracellular matrices related proteins and epithelial-mesenchymal transition markers in borderline PTs led these authors to hypothesize a model of deposition and degradation leading to ECM remodeling and EMT acquisition ...
DALLAS, March 17, 2021 -- Immediate angiography, rather than the standard computed tomography (CT scan), reduced stroke treatment time and was linked to improved recovery, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
Standard emergency department treatment for stroke patients involves a CT scan, which uses X-rays to pinpoint the presence and location of a blood clot. Angiography is an advanced X-ray imaging method that uses a catheter, or thin tube, inserted into the blood vessel to find the location and size ...
DALLAS, March 17, 2021 -- Stroke patients treated via a mobile stroke unit (MSU) received clot-busting medications faster and more often - and recovered significantly better than patients who receive regular emergency care by standard ambulance, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
"Our goal in this study was to treat patients on the mobile stroke unit within an hour of the onset of their stroke ...
CHARLOTTESVILLE, Va. - Progress in the field of integrated circuits is measured by matching, exceeding, or falling behind the rate set forth by Gordon Moore, former CEO and co-founder of Intel, who said the number of electronic components, or transistors, per integrated circuit would double every year. That was more than 50 years ago, and surprisingly his prediction, now called Moore's Law, came true.
In recent years, it was thought that the pace had slowed; one of the biggest challenges of putting more circuits and power on a smaller chip is managing heat.
A multidisciplinary group that includes Patrick E. Hopkins, a professor in the University of Virginia's Department of Mechanical and Aerospace ...
In 1958, a magnitude 7.8 earthquake triggered a rockslide into Southeast Alaska's Lituya Bay, creating a tsunami that ran 1,700 feet up a mountainside before racing out to sea.
Researchers now think the region's widespread loss of glacier ice helped set the stage for the quake.
In a recently published research article, scientists with the University of Alaska Fairbanks Geophysical Institute found that ice loss near Glacier Bay National Park has influenced the timing and location of earthquakes with a magnitude of 5.0 or greater in the area during the past century.
Scientists have ...
Veterans with PTSD who practiced the Transcendental Meditation technique showed significant reductions in PTSD symptom severity, according to a new study published today in Journal of Traumatic Stress. Fifty percent of the meditating veterans no longer met criteria for PTSD after three months compared to only 10 percent of controls. The randomized controlled study also showed significant reductions in veterans' symptoms of depression and anxiety, and sleep difficulties.
"Transcendental Meditation is a non-trauma-focused, easy-to-learn technique that was found in this study to improve PTSD symptoms, likely through the experience of physical rest," said Mayer Bellehsen, Ph.D., director of the Unified Behavioral Health Center for Military Veterans and their Families, ...
The introduction of a sugar tax, increasing the price of fizzy drinks and other products high in sugar content, has had only a limited, moderate effect in shifting people's dietary habits and behaviours, according to a new study.
Fresh research from an international team of economists published in the journal Social Science & Medicine, focused on the impact of a sugar tax on people's shopping baskets comparing customer spending in Catalonia in Spain (where a tax had been introduced), with the rest of the country (where it had not been) from May 2016 - April 2018.
A sugar-sweetened beverages (SSB) tax was in introduced in Catalonia in May 2017, but not for the rest of ...
A rare pulmonary disease that is linked to bats has made Alberta home, according to new research led by provincial lab scientists.
Infectious disease experts at Alberta Precision Laboratories (APL) and the University of Alberta have confirmed that histoplasmosis - a fungal infection transmitted through bat and bird droppings - is now found in Alberta. Their study extends the known range of the disease much further northwest from its traditional home in the central United States and parts of southern Ontario and Quebec.
"We were surprised at how many cases were locally acquired, as histoplasmosis has ...
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
For children in this age group who have only one copy of F508del mutation - or about 40 percent of patients with cystic fibrosis ...
A UCLA-led research team has identified a chemical cocktail that enables the production of large numbers of muscle stem cells, which can self-renew and give rise to all types of skeletal muscle cells.
The advance could lead to the development of stem cell-based therapies for muscle loss or damage due to injury, age or disease. The research was published in Nature Biomedical Engineering.
Muscle stem cells are responsible for muscle growth, repair and regeneration following injury throughout a person's life. In fully grown adults, muscle stem cells are quiescent -- they remain inactive until they are called to respond to injury by self-replicating and creating all of the cell types necessary to repair damaged tissue.
But that regenerative capacity decreases as people ...
